GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Cyclically Adjusted Price-to-FCF

Sumitomo Pharma Co (Sumitomo Pharma Co) Cyclically Adjusted Price-to-FCF : 15.88 (As of Apr. 27, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Sumitomo Pharma Co's current share price is $2.70. Sumitomo Pharma Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.17. Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF for today is 15.88.

The historical rank and industry rank for Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

DNPUF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 5.01   Med: 12.47   Max: 35.42
Current: 15.16

During the past years, Sumitomo Pharma Co's highest Cyclically Adjusted Price-to-FCF was 35.42. The lowest was 5.01. And the median was 12.47.

DNPUF's Cyclically Adjusted Price-to-FCF is ranked better than
78.46% of 325 companies
in the Drug Manufacturers industry
Industry Median: 32.81 vs DNPUF: 15.16

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $-1.026. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.17 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sumitomo Pharma Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Cyclically Adjusted Price-to-FCF Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.24 11.18 11.11 8.10 6.32

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.47 6.32 9.14 10.91 18.16

Competitive Comparison of Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF falls into.



Sumitomo Pharma Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=2.70/0.17
=15.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sumitomo Pharma Co's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.026/106.8000*106.8000
=-1.026

Current CPI (Dec. 2023) = 106.8000.

Sumitomo Pharma Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.000 95.700 0.000
201406 0.000 98.000 0.000
201409 0.000 98.500 0.000
201412 0.000 97.900 0.000
201503 0.000 97.900 0.000
201506 0.000 98.400 0.000
201509 0.000 98.500 0.000
201512 0.000 98.100 0.000
201603 0.000 97.900 0.000
201606 0.000 98.100 0.000
201609 0.000 98.000 0.000
201612 0.000 98.400 0.000
201703 0.000 98.100 0.000
201706 0.394 98.500 0.427
201709 0.356 98.800 0.385
201712 0.270 99.400 0.290
201803 0.853 99.200 0.918
201806 -0.267 99.200 -0.287
201809 0.250 99.900 0.267
201812 0.206 99.700 0.221
201903 0.615 99.700 0.659
201906 0.119 99.800 0.127
201909 0.431 100.100 0.460
201912 0.079 100.500 0.084
202003 0.137 100.300 0.146
202006 -0.030 99.900 -0.032
202009 0.535 99.900 0.572
202012 1.899 99.300 2.042
202103 0.586 99.900 0.626
202106 -0.817 99.500 -0.877
202109 -0.001 100.100 -0.001
202112 0.756 100.100 0.807
202203 0.411 101.100 0.434
202206 0.173 101.800 0.181
202209 0.259 103.100 0.268
202212 0.431 104.100 0.442
202303 -0.902 104.400 -0.923
202306 -2.394 105.200 -2.430
202309 -0.826 106.200 -0.831
202312 -1.026 106.800 -1.026

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sumitomo Pharma Co  (OTCPK:DNPUF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Sumitomo Pharma Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.